staceywhite, Author at European Medical Journal - Page 50 of 195

Sickle Cell Thalassaemia and Overlapping Syndrome

Sickle cell disease (SCD) is a genetic condition caused by mutations in the haemoglobin (Hb) gene, resulting in various complications. One…

Review of the European Association for Haemophilia and Allied Disorders (EAHAD) Annual Congress 2024

The congress featured an enthusiastic welcome from 2024 EAHAD Congress President, Wolfgang Miesbach, who discussed the ongoing innovation…

Optimising Outcomes of Haemophilia Treatment

The 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) took place in Frankfurt, Germany, from…

Navigating Adjuvant Melanoma Treatment Choices

Navigating Adjuvant Melanoma Treatment Choices – The typical patient for whom adjuvant therapy may be considered, and provide details on…

Should Coronary Artery Fistula Be Treated?

Coronary artery fistulas (CAF) are communications between a coronary artery and a major vessel or a cardiac chamber.1 More than 90% of…

Contraceptive Use Among Females with HIV

HIV is an epidemic in Kenya. Females living with HIV (FLHIV) have an eight-fold increased risk of a pregnancy-related death compared to…

Interview: Alessia Callegari

My venture into paediatric cardiology began during my medical studies at the University of Padua, Italy. During my clinical rotation in…

Recent Perspectives of Anti-TNF Combination Therapy for Inflammatory Bowel Disease

This News Feature explores the current use of anti-TNF combination therapy with immunomodulators for Crohn’s disease and ulcerative colitis in adults and children.

Author Response to: Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’

The aim of our work was to underline that surgery can be applied as a first-line treatment. This was also the shared starting assumption…

Optimal Timing of Anti-TNF Therapy for Inflammatory Bowel Disease

This News Feature explores the current opinions of leading gastroenterologists on the early use of anti-TNFs for Crohn’s disease and ulcerative colitis.